Collaboration between Premier, AstraZeneca and leading health
systems will leverage real-world data, artificial
intelligence-powered technologies and scalable solutions to help
improve the health of patients and lower the cost of care.
Premier, Inc. (NASDAQ: PINC) is excited to announce a strategic
partnership with AstraZeneca called Uncover CKD - Care Collective
aiming to identify patients with undiagnosed clinical chronic
kidney disease (CKD); raise awareness of undiagnosed CKD among
healthcare providers; and inform U.S. health systems that want to
improve or develop and implement their strategies for CKD
diagnosis, treatment and management.
In the U.S., more than 37 million adults have CKD, and the
prevalence is rising. Of these adult patients, 90 percent do not
know they have CKD. Total inflation-adjusted Medicare expenditures
for patients with end-stage renal disease increased to $53 billion
in 2019. Among CKD patients, the cost of preventable
hospitalizations is $79 million.
Through collaborative initiatives and scalable solutions from
across the Premier enterprise, including its PINC AI™ technology
and services platform, the Uncover CKD - Care Collective is
addressing undiagnosed and rising CKD and the resulting economic
burden to the U.S. healthcare system. The partnership with
AstraZeneca demonstrates a commitment to implement and learn about
innovative approaches to driving optimization of guideline-directed
medical therapy for patients.
“We’re thrilled to be working with AstraZeneca and Premier
member health systems to help solve the myriad challenges CKD
presents to patients and our healthcare system,” said Leigh
Anderson, Chief Operating Officer, Premier. “The Uncover CKD - Care
Collective initiative highlights the impact collaborative
partnerships across life sciences organizations and health systems
– coupled with actionable real-world data (RWD), artificial
intelligence (AI)-powered clinical and operational solutions, and
best-practice consulting and collaboratives – can have in improving
the care and cost of treating chronic diseases. As our collective
work moves the needle on the rate of CKD diagnosis, those patients
previously undiagnosed can begin to be treated and their conditions
managed, limiting down-the-line costs associated with more severe
disease stages.”
The Uncover CKD - Care Collective is poised to make significant
strides in improving CKD diagnosis and advancing patient care
through the utilization of:
- PINC AI™ Applied Sciences (PAS) RWD leveraging the robust PINC
AI™ Healthcare Database, laboratory data and technology to identify
high-volume areas of unidentified, at-risk patients; screen
undiagnosed CKD patients, estimate prevalence and report
hospital-specific patient counts; and describe patient
characteristics and the clinical and economic outcomes of
undiagnosed CKD. This discovery phase work has been completed and
findings disseminated to characterize the burden of CKD across the
health systems, prioritize and focus hospital-level initiatives,
and commit to sustainable organizational change.
- PAS Improvement Science’s Health System Awareness Package,
including provider and patient education, provider resources and
workflow processes as well as support for participating health
systems through provider engagement – all created to be scaled
broadly across Premier’s health system network.
- PINC AI™ Stanson AI-powered technology, including clinical
decision support and real-time alerts integrated into the provider
workflow, to help strategically modify provider behavior to improve
CKD screening, diagnosis and care quality.
- PINC AI™ Advisory Services to actively engage physicians,
foster mutual accountability and drive clinical transformation and
quality improvement efforts around CKD diagnosis, treatment and
management throughout the health systems.
- Premier Pharmacy and Group Purchasing Organization resources to
optimize medication management protocols and streamline operational
processes for enhanced efficiency and positive patient
outcomes.
- PINC AI™ Population Health Management Collaborative, including
member Accountable Care Organizations (ACOs) and those on the
transformation to value-based care, to facilitate idea exchange and
best practice sharing.
- Health system collaboration to share project outcomes, publish
a white paper, develop a poster presentation for the National
Kidney Foundation and present findings at Premier’s 2024
Breakthroughs Conference & Exhibition.
“Through commitment to AstraZeneca’s medical missions of putting
patients first and following the science, the Uncover CKD program
is applying RWD to create urgency to diagnose and treat patients
with CKD. With this innovative partnership we are leveraging
relationships with health systems to improve care for 2.8 million
patients identified to benefit from earlier CKD diagnosis and
treatment,” said Rachele Berria, Vice President and Medical Head,
US BioPharmaceuticals, AstraZeneca.
Health System Selection Criteria
In the selection of target health systems for the Uncover CKD -
Care Collective, the project team considered disease burden,
patient composition (e.g., age, sex, race, ethnicity), payer
composition (e.g., Medicaid, Medicare, uninsured), hospital region
(geographic diversity), urbanicity of served population, teaching
status and hospital size. Priority was given to health systems
serving many socially disadvantaged patients (i.e., health equity).
For patient outreach efforts, the project team provided screening
algorithms to the target sites so that they can identify socially
disadvantaged patients with undiagnosed CKD for targeted
outreach.
Hospitals and health systems in the U.S. can request access to
the online PINC AI™ Community “Chronic Kidney Disease (CKD):
Diagnosis and Mgmt.” to obtain outreach materials that have been
developed as part of the Uncover CKD Project such as educational
resources and tools for patients and healthcare professionals.
Premier will work with respective hospitals or health systems to
provide relevant resources, based on needs. For example, these
resources could include the CKD Care Journey Roadmap, CKD Health
Equity Primer, clinical decision support documentation (algorithms)
and other digitized resources.
About Premier, Inc.
Premier, Inc. (NASDAQ: PINC) is a leading healthcare improvement
company, uniting an alliance of more than 4,350 U.S. hospitals and
health systems and approximately 300,000 other providers to
transform healthcare. With integrated data and analytics,
collaboratives, supply chain solutions, consulting and other
services, Premier enables better care and outcomes at a lower cost.
Premier plays a critical role in the rapidly evolving healthcare
industry, collaborating with members to co-develop long-term
innovations that reinvent and improve the way care is delivered to
patients nationwide. Headquartered in Charlotte, N.C., Premier is
passionate about transforming American healthcare. Please visit
Premier’s news and investor sites on www.premierinc.com; as well as
X, Facebook, LinkedIn, YouTube, Instagram and Premier’s blog for
more information about the company.
About the PINC AI™ Platform
PINC AI™ is the technology and services platform of Premier,
Inc. (NASDAQ: PINC). With more than 20 years’ worth of cost,
quality and operational data gleaned from 45 percent of U.S.
hospital discharges, 2.7 billion hospital outpatient and clinic
encounters and 177 million physician office visits, the PINC AI™
platform provides actionable intelligence to help improve outcomes,
support improved financial performance and enable success in new,
alternative payment models. PINC AI™ incorporates the 100 Top
Hospitals ® Program that inspires hospital and health system
leaders to pursue higher performance and deliver added value to
their patients and communities. PINC AI™ offerings rely on advanced
analytics to identify improvement opportunities; support
award-winning Strategic Collaboratives for value-based care,
maternal and infant health, workforce innovation, and health
equity; and consulting services for clinical and operational
design, and workflow solutions to hardwire sustainable change. The
PINC AI™ platform is also the data engine powering Premier’s newest
brands – Remitra® and Contigo Health®. With a leading network of
provider organizations, the PINC AI™ platform accelerates ingenuity
and serves as a large-scale innovation catalyst in healthcare. PINC
AI™ offerings and capabilities can be followed on X and
LinkedIn.
Forward-Looking Statements
Statements made in this release that are not statements of
historical or current facts, including but not limited to those
relating to Premier's ability to advance its long-term strategies
and develop innovations for, transform, and improve healthcare, and
the intended or expected performance or utility of Premier's
products and services, are “forward-looking statements” within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements may involve known and unknown risks,
uncertainties and other factors that may cause performance or
achievements to be materially different from historical results or
from any future performance or achievements expressed or implied by
such forward-looking statements. Accordingly, readers should not
place undue reliance on any forward-looking statements.
Forward-looking statements may include comments as to Premier’s
beliefs and expectations as to future events and trends affecting
its business and are necessarily subject to uncertainties, many of
which are outside Premier’s control. More information on potential
factors that could affect Premier’s financial results is included
from time to time in the “Cautionary Note Regarding Forward-Looking
Statements,” “Risk Factors” and “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” sections
of Premier’s periodic and current filings with the SEC, which are
also made available on Premier’s website at
investors.premierinc.com. Forward-looking statements speak only as
of the date they are made, and Premier undertakes no obligation to
publicly update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise that
occur after that date, or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240508239890/en/
public_relations@premierinc.com
Premier (NASDAQ:PINC)
Historical Stock Chart
From Sep 2024 to Oct 2024
Premier (NASDAQ:PINC)
Historical Stock Chart
From Oct 2023 to Oct 2024